Blood bank reagents

Ended Awarded Last action

Contract number
36C24620N0175
Awardee
Awarding agency
Obligated
$274,145

Award facts

Contract value 51% obligated
  • $326,919.38 Current, with exercised options
  • $538,018.90 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Norcross, GA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00016 $3,981
Exercise an Option P00014 $53,175
Exercise an Option P00013 $0
Supplemental Agreement for work within scope P00012 -$170
Supplemental Agreement for work within scope P00011 $2,800
Exercise an Option P00010 · Blood bank reagents- exercise option year 3 $53,174
Exercise an Option P00009 $0
Funding Only Action P00008 -$3,370
Exercise an Option P00007 · Blood bank reagents- exercise option year 2 $52,775
Supplemental Agreement for work within scope P00006 · Blood bank reagents- increase quantity for line item 9. $3,200
Exercise an Option P00005 · Blood bank reagents- notice to exercise option year 2 $0
Other Administrative Action P00004 · Blood bank reagents- modification to change line item quantity. -$170
Exercise an Option P00003 $55,975
Exercise an Option P00002 · Blood bank reagents- exercise option year 1 $0
Original award $52,775
Show all 15

About this award

This is a federal contract award for blood bank reagents, awarded to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The contract, with a ceiling value of $538,018.90, is a Delivery Order contract with a Firm Fixed Price pricing type. It was awarded on October 1, 2019 by the Veterans Integrated Service Network 6, a civilian agency, and has an ultimate completion date of September 30, 2024. The contract is not set aside and is part of a larger General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. Through this contract, Immucor will provide specialized blood bank reagents, diagnostic test kits, blood analyzers, and related consumables to support medical testing and healthcare operations across various federal networks.

Quick answers

Who was awarded contract 36C24620N0175?

36C24620N0175 was awarded to Immucor Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on October 1, 2019.

How much is contract 36C24620N0175 worth?

The government has obligated $274,145 on 36C24620N0175. Its current value, with exercised options, is $326,919. Its potential value, with all options, is $538,019.

Is contract 36C24620N0175 an order under another contract?

Yes. 36C24620N0175 is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36C24620N0175 competed?

The extent of competition for 36C24620N0175 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award